Pharming Group NV operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharming Group with three other
miscellaneous service companies in Europe:
Basilea Pharmaceutica Limited
sales of 90.67 million Swiss Francs [US$93.77 million]
of which 100%
was Pharmaceutical Products),
(361.65 million Polish New Zlotys [US$98.49 million]
of which 59%
was Insulin (Bioton SA)), and
based in Germany
(66.79 million Euro [US$77.94 million]
of which 74%
was Partnered Discovery).
Sales increased substantially in 2017:
During the year ended December of 2017, sales at
Pharming Group were 89.62 million Euro (US$104.57 million).
increase of 464.6%
versus 2016, when the company's sales were 15.87 million Euro.